(metastasize) to your lymph nodes and other areas of your body. IDC is serious and should be treated to remove the cancer and reduce the chance of it coming back (recurring). When IDC is detected and treated early (before it spreads beyond the breast), it has a high survival rate. ...
This flat lesion is referred to as ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). Considering neoplasm leads one to an effectiveness survival analysis compared to the case that neoplasm is not attended. The objective of this research is to analyze statistically survival of...
1993; Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma. Br J Cancer 68:115–8. CAS PubMed Google Scholar Gamel JW, Vogel RL. 1993; A model of long-term survival following adjuvant therapy for stage 2 breast cancer. Br J Cancer 68: 1167–70. CAS ...
The Ki-67 status serves as a predictor for pathological complete response before neoadjuvant chemotherapy, being associated with high risk for metastasis or recurrence, poorer prognosis, and reduced survival, thus marking more aggressive forms of breast cancer [37, 38]. In this study, the DH was...
these include age, family history, breast density, and hormone therapy.22However, it is commonly considered that the prognosis of DCIS is superior to IDC. DCIS is not considered a life-threatening disease and is linked to a high rate of overall survival and a normal life expectancy.23After ...
Although ductal carcinoma in situ (DCIS) is a non-obligate precursor to ipsilateral invasive breast cancer (iIBC), most DCIS lesions remain indolent. Hence, overdiagnosis and overtreatment of DCIS is a major concern. There is an urgent need for prognosti
Although the treatments of breast cancer have made great progress, the five-year survival rate of patients with early breast cancer can reach more than 85% and >120,000 people are expected to die from breast cancer in China by 20223,4. Therefore, the development of accurate molecular ...
The locoregional recurrence rate in patients with DCIS treated with BCT is similar to that in patients with early-stage invasive breast cancer treated with... Nadeem Q. Mirza, Georges Vlastos, Funda Meric, Aysegul A. Sahin, S. Eva Singletary, Lisa A. Newman - 《Annals of Surgical Oncology...
Invasive ductal carcinoma describes the type of tumor in about 80 percent of people with breast cancer. The five-year survival rate is quite high --almost 100 percent when the tumor is caught and treated early. How long can you live with invasive ductal carcinoma?
Although the treatments of breast cancer have made great progress, the five-year survival rate of patients with early breast cancer can reach more than 85% and >120,000 people are expected to die from breast cancer in China by 20223,4. Therefore, the development of accurate molecular ...